Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 37
Filter
1.
Dose Response ; 13(1)2015.
Article in English | MEDLINE | ID: mdl-26691866

ABSTRACT

Presence of individual fatty acid ethyl esters (FAEEs) in meconium is considered to be a reliable biomarker of prenatal alcohol exposure, and their concentration has been found to be linearly associated with poor postnatal development, supporting the widely extended idea that ethanol is a non-threshold teratogen. However, a growing number of epidemiological studies have consistently found a lack of adverse short- and long-term fetal outcomes at low exposure levels. We therefore aimed to investigate the relationship between the concentration of individual FAEEs and prenatal alcohol exposure in meconium samples collected within the first 6 to 12?h after birth from 182 babies born to abstainer mothers and from 54 babies born to women who self-reported either light or moderate alcohol ingestion in the second or third trimester of pregnancy. In most cases, the individual FAEE concentrations were negligible and not significantly different (P >0.05) between exposed and control babies. The concentrations appeared to increase linearly with the dose only in the few babies born to mothers who reported >3 drinks/week. These results provide evidence that the correlation between prenatal alcohol exposure and individual FAEE concentrations in meconium is non-linear shape, with a threshold probably at 3 drinks/week.

2.
J Obstet Gynaecol ; 35(8): 871-2, 2015.
Article in English | MEDLINE | ID: mdl-26033169

ABSTRACT

Information on the safety of first-trimester exposure to diagnostic magnetic resonance imaging (MRI) remains scarce. We are reporting a case series of 15 consecutive pregnant women who underwent an MRI scan with a 1.5-Tesla scanner of either the head (n = 5), cervical spine (n = 4), lumbar spine (n = 4), pelvis (n = 1) or knee (n = 1) in their first trimester of pregnancy (mean gestational age at exposure: 3.8 weeks). Patients were prospectively followed up until the completion of their pregnancy. Two cases received gadolinium as a contrast agent. There were 15 babies born alive. Of them, one baby was born with the left kidney not visualised by ultrasound examination, and another one with an overlapping toe in the right foot. None of these abnormalities were considered by the authors related to the MRI exposure. In conclusion, our study provides support to published preliminary evidence regarding the safety of MRI in the first-trimester pregnant women.


Subject(s)
Magnetic Resonance Imaging/adverse effects , Pregnancy Trimester, First , Adult , Female , Follow-Up Studies , Humans , Pregnancy
3.
J Obstet Gynaecol ; 35(2): 125-30, 2015 Feb.
Article in English | MEDLINE | ID: mdl-25093607

ABSTRACT

The present study was designed to investigate if exposure to dried ginger during pregnancy would increase the risk of adverse fetal and neonatal outcomes. Participants consisted of 159 singleton pregnant women who received dried ginger as a herbal medication. We also included a control group of 306 pregnant women who had not been exposed to any herbal medication or any known teratogen. No increased risk of major malformations was detected in exposed women (OR = 4.9; 95% CI 0.9-25.5; p = 0.051). The incidence of stillbirths in the exposed group was marginally higher than in the controls (OR = 7.8; 95% CI 0.9-70.3; p = 0.05). The risk was more evident when the exposed group was compared with the general population in the Republic of Korea (OR = 7.9; 95% CI 2.9-21.4; p < 0.0001). Other fetal and neonatal study outcomes investigated in the exposed group were similar (p > 0.05) to the controls. In conclusion, dried ginger does not appear to be a major teratogen. However, due to the limitations of the study, e.g. the large variability in the dose of dried ginger in the exposed group, as well as the concomitant exposure to other herbal medications, the increased incidence of stillbirths requires confirmation in larger cohort studies.


Subject(s)
Congenital Abnormalities/epidemiology , Digestive System Diseases/drug therapy , Phytotherapy , Plant Preparations/therapeutic use , Pregnancy Complications/drug therapy , Stillbirth/epidemiology , Zingiber officinale , Adult , Confounding Factors, Epidemiologic , Female , Humans , Incidence , Male , Plant Preparations/administration & dosage , Pregnancy , Republic of Korea/epidemiology
4.
J Obstet Gynaecol ; 33(2): 160-2, 2013 Feb.
Article in English | MEDLINE | ID: mdl-23445139

ABSTRACT

The safety of domperidone in pregnancy remains unknown. Therefore, the study aimed to prospectively evaluate the fetal outcomes of women who were taking domperidone during pregnancy. In a prospective cohort study design, 120 1st- trimester pregnant women who were taking domperidone for controlling gastrointestinal tract symptoms and 212 age-matched pregnant women not exposed to any potential teratogenic agent, were followed-up until delivery. In the case group, domperidone was indicated for control of functional gastrointestinal disorders in 59.2%, the maximum dose was 30 mg/day and exposure occurred between 2(+4) and 20 weeks' gestation. Fetal outcomes including gestational age at birth, birth weight and length, head circumference at birth, and 1- and 5-min Apgar score were similar in the two study groups. There were three babies born with malformations in each group (OR = 0.6; 95% CI 0.1, 2.8). In conclusion, domperidone does not appear to be a major human teratogen. However, our findings require further confirmation in larger studies.


Subject(s)
Antiemetics/adverse effects , Birth Weight/drug effects , Domperidone/adverse effects , Fetal Development/drug effects , Abnormalities, Drug-Induced/etiology , Adult , Female , Humans , Infant, Newborn , Pregnancy , Prospective Studies
5.
Intern Med J ; 43(5): 513-8, 2013 May.
Article in English | MEDLINE | ID: mdl-23181560

ABSTRACT

BACKGROUND/AIM: Little is known about exposures to low radiation doses in the first trimester of pregnancy and deterministic adverse effects in the offspring, and risks are extrapolated from catastrophic events or from exposures to radiotherapy. The study aimed to assess the foetal and neonatal outcomes of pregnant women exposed to radiodiagnostic procedures with abdominal or lumbar irradiation. METHODS: In a prospective cohort design, we studied the foetal and neonatal outcomes in 115 singleton pregnant women who required abdominal or lumbar radiodiagnostic procedures without the administration of radionucleotides, and in 527 age-matched (± 2 years) control pregnant women. RESULTS: In the exposed group, lumbar spine radiography (33.9%), plain abdominal radiography (16.5%) and upper gastrointestinal tract radiography with abdominal irradiation (15.7%) were the most common radiodiagnostic procedures. Major congenital malformations were identified in two (1.9%) babies born in the exposed group and in two (0.4%) babies born in the control group (odds ratio = 4.7; 95% confidence interval 0.7-33.6; P = 0.15). The rest of the foetal and neonatal outcomes was similar in the two groups except by a marginally higher rate of admissions to the neonatal intensive care unit among babies born to exposed women (odds ratio = 2.9; 95% confidence interval 1.0-9.4; P = 0.06). CONCLUSION: Our results indicate that X-ray and computed tomography scan exposure involving abdominal irradiation without the administration of radionucleotides is not associated with adverse foetal and neonatal deterministic outcomes. Efforts are required to reduce the use of radiodiagnostic procedures for general check-ups in childbearing age women.


Subject(s)
Congenital Abnormalities/epidemiology , Fetus/radiation effects , Pregnancy Outcome/epidemiology , Pregnancy Trimester, First/radiation effects , Prenatal Exposure Delayed Effects/epidemiology , Radiography, Abdominal , Adult , Cohort Studies , Congenital Abnormalities/diagnosis , Female , Humans , Infant, Newborn , Pregnancy , Prenatal Exposure Delayed Effects/diagnosis , Prospective Studies , Radiation Dosage , Radiography, Abdominal/adverse effects
6.
J Obstet Gynaecol ; 32(3): 227-9, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22369393

ABSTRACT

The present study prospectively assessed pregnancy outcome of women taking probiotics during the periconceptional period. A group of 104 women who had taken Lactobacillus in early pregnancy and 200 age- and parity-matched control pregnant women exposed to non-teratogenic agents were also recruited into the study and followed-up prospectively. Median gestational age of women exposed to Lactobacillus was 5.2 (range: 1.9-17.6) weeks. Exposure was at a mean dose of 510 mg/day for a median of 4.0 days (range: 1-90 days). In the exposed group, pregnancy outcomes included 96 live births and eight spontaneous abortions versus 187 live births and 21 spontaneous abortions in the non-exposed group. There was no statistical difference in adverse pregnancy outcomes, including the number of spontaneous abortions, pre-term births as well as a low birth weight between the two groups (p > 0.05). In the exposed group, there were two (2.1%) major congenital malformations in comparison with five (2.7%) in the comparison group (p = 0.7). In conclusion, no association was identified between ingestion of Lactobacillus in early pregnancy for a limited period of time and adverse pregnancy outcomes. However, rare pregnancy outcomes may have been missed due to the limited sample size included in the study.


Subject(s)
Abortion, Spontaneous/etiology , Congenital Abnormalities/etiology , Lactobacillus , Live Birth , Maternal Exposure/adverse effects , Premature Birth/etiology , Probiotics/adverse effects , Abortion, Spontaneous/epidemiology , Adult , Birth Weight , Congenital Abnormalities/epidemiology , Female , Follow-Up Studies , Gestational Age , Humans , Infant, Low Birth Weight , Infant, Newborn , Live Birth/epidemiology , Pregnancy , Pregnancy Trimester, First , Premature Birth/epidemiology , Prospective Studies , Single-Blind Method
7.
J Obstet Gynaecol ; 31(7): 586-8, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21973128

ABSTRACT

Despite barium being used as a contrast media for decades, the specific assessment of its safety in pregnant women is scarce. We are reporting the favourable pregnancy outcome in women who were inadvertently exposed to barium swallow and associated ionising radiation, early in pregnancy. A control group of age- and gravidity-matched unexposed pregnant women was also included. There were 32 live-born babies in the exposed group and 94 in the control group. Women had undergone diagnostic upper gastrointestinal tract (UGT) fluoroscopic examination at 3.3 ± 1.5 weeks' gestation. Estimated maternal radiation dose secondary to barium swallow varied widely, the maximum dose was estimated to be 2.45 mSv. Similar pregnancy outcomes were observed between the groups. The number of babies born with major malformations was not significantly different (p = 1.0) between cases and controls: one (3.1%) vs three (3.2%), respectively. In conclusion, our small prospective cohort study of women suggests no association between inadvertent exposure to ionising radiation and barium sulphate during fluoroscopic barium swallow and adverse fetal outcomes.


Subject(s)
Barium Sulfate/adverse effects , Contrast Media/adverse effects , Gastrointestinal Tract/diagnostic imaging , Gestational Age , Pregnancy Outcome , Abnormalities, Drug-Induced/epidemiology , Adult , Female , Fluoroscopy , Humans , Pregnancy , Pregnancy Trimester, First , Prospective Studies
8.
J Obstet Gynaecol ; 30(6): 559-62, 2010.
Article in English | MEDLINE | ID: mdl-20701501

ABSTRACT

X-ray exposure, especially if directed to the abdominal region, is of major concern for pregnant women and their physicians. In this study, favourable long-term outcomes are reported in a series of babies born to women inadvertently exposed to barium enema, and associated ionising radiation, early in pregnancy. Six singleton babies were vaginally delivered without any evidence of gross malformations. There was one voluntary abortion. Follow-up on five of the babies was performed over the course of at least 4 years. All the children were deemed healthy and had developed milestones according to their age. Our findings support larger studies suggesting barium enema is not a teratogenic agent. Collectively, this research can be used to counsel women undergoing radiological procedures early in pregnancy.


Subject(s)
Barium Sulfate , Pregnancy/radiation effects , Adult , Contrast Media , Enema , Female , Humans , Pregnancy Trimester, First
9.
J Obstet Gynaecol ; 30(6): 563-6, 2010.
Article in English | MEDLINE | ID: mdl-20701502

ABSTRACT

No information is currently available on the safety of methylephedrine, a component of various cold medications available in South Korea. With previous approval by an Institutional Review Board, 349 women inadvertently exposed to methylephedrine during the 1st trimester of pregnancy and an age- and gravidity-matched control group, were enrolled in a prospective cohort study. Study outcomes, for example gestational age at birth, birth weight and major and minor malformations were evaluated in 282 cases and 280 controls. Exposure to methylephedrine was at a gestational age of 4.0 weeks (median), at doses ranging from 52.5 to 1,575 mg/day, for a median duration of 3 (range: 1-30) days. No differences were observed between cases and controls in any of the pregnancy outcomes studied. There were 4/265 (1.5%) babies born with major malformations in the case group and 4/260 (1.5%) in the control group. In conclusion, inadvertent exposure to methylephedrine as a component of over-the counter oral cold remedies in early pregnancy was not associated with an increased rate of adverse pregnancy outcomes. Co-exposure with acetaminophen, cigarette smoking or alcohol did not appear to modify the outcomes.


Subject(s)
Birth Weight/drug effects , Ephedrine/analogs & derivatives , Maternal Exposure , Pregnancy Outcome , Abnormalities, Drug-Induced/etiology , Adult , Cohort Studies , Ephedrine/adverse effects , Female , Gestational Age , Humans , Pregnancy , Pregnancy Trimester, First , Prospective Studies , Republic of Korea
10.
J Obstet Gynaecol ; 29(8): 694-7, 2009 Nov.
Article in English | MEDLINE | ID: mdl-19821659

ABSTRACT

We assessed the pregnancy outcome of nine women inadvertently transfused with acitretin-contaminated blood products in South Korea. A total of 18 women matched to cases by age, gravidity, and singleton- or twin-pregnancy, and who were transfused with blood products not contaminated with acitretin, was also recruited. There were nine babies born in the case group. No differences (p > 0.05) were observed between cases and controls in the gestational age at delivery (38.3 +/- 1.6 weeks vs 37.8 +/- 2.2 weeks), birth weight (3,146 +/- 874 g vs 3,106 +/- 568 g), rate of pre-term deliveries (22.2% vs 11.1%) and rate of low birth weight (<2,500 g) (33.3% vs 16.7%). There was no case of malformation or neurological abnormalities born in either group. In conclusion, inadvertent exposure to acitretin-contaminated blood products was not associated with adverse pregnancy outcomes, probably because of the removal of acitretin and etretinate during the manufacturing process of blood products.


Subject(s)
Acitretin/blood , Biological Products/chemistry , Keratolytic Agents/blood , Pregnancy Outcome , Transfusion Reaction , Adult , Case-Control Studies , Drug Contamination , Female , Gestational Age , Half-Life , Humans , Infant, Newborn , Pregnancy , Psoriasis/blood , Psoriasis/drug therapy , Teratogens
11.
J Obstet Gynaecol ; 28(5): 482-4, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18850419

ABSTRACT

Several studies have reported an association between depression and folic acid deficiency. We investigated whether intake of prenatal multivitamins containing folic acid (MVandFA) was associated with decreased rates of depression among pregnant women. A questionnaire was given to 1,314 low-risk pregnant women. Of them, 1,277 (97.2%) women completed the questionnaire. The overall prevalence of depression was 8.1%. Of 652 participants who did not take MVandFA, 9.4% had depression, whereas 6.9% of 624 women who had MVandFA had depression (p = 0.11). In a multivariate logistic regression analysis, family history of depression (adjusted OR 3.7; 95% CI 1.9-7.3) and premenstrual syndrome (adjusted OR 3.0, 95% CI 1.8-4.8) were identified as risk factors for depression during pregnancy. In conclusion, intake of MVandFA was not associated with lower rates of depression during pregnancy whereas family history of depression and personal history of premenstrual syndrome were significant risk factors.


Subject(s)
Depression/epidemiology , Depression/prevention & control , Folic Acid/administration & dosage , Vitamins/administration & dosage , Depression/etiology , Female , Humans , Logistic Models , Pregnancy , Premenstrual Syndrome/complications , Prenatal Care , Prevalence , Risk Factors , Surveys and Questionnaires
12.
Int J Neurosci ; 118(9): 1299-315, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18698512

ABSTRACT

Piglets appear to be neurologically sensitive to intrapartum asphyxia. Our aim was to investigate the short-term neurophysiologic consequences of intrapartum asphyxia in piglets. We studied 10 piglets suffering intrapartum asphyxia and 10 control piglets. Glucose and blood gas levels, tympanic membrane temperature, and body weight were measured within the first 2 min after birth. Animals were followed up for a 5-day period. As surrogated markers of piglets' neurological function, a viability score and the time elapsed from birth to the first contact with the maternal udder were recorded. In the control group, temperature and blood pH levels at birth were significantly higher (p < or = .001), whereas calcium, lactate and PCO2 levels were statistically lower (p < or = .05) than in the piglets experiencing intrapartum asphyxia. Lower temperature and blood pH levels as well as higher blood PCO2 and lactate levels were observed in piglets with lower viability scores and in piglets with prolonged times until first udder contact. At the end of the study, asphyxiated piglets weighed on average 200 g less (p = .023) than control piglets. In conclusion, intrapartum asphyxia in spontaneously born piglets was associated with signs of acute neurological dysfunction and lower weight gain, supporting the hypothesis that they may be used as a naturalistic model for the study of asphyxia in newborns.


Subject(s)
Asphyxia/physiopathology , Parturition/physiology , Acidosis, Respiratory/diagnosis , Acidosis, Respiratory/metabolism , Acidosis, Respiratory/physiopathology , Animals , Animals, Newborn , Asphyxia/diagnosis , Asphyxia/metabolism , Blood Gas Analysis/methods , Blood Glucose/metabolism , Blood Glucose/physiology , Electrolytes/metabolism , Female , Parturition/metabolism , Random Allocation , Swine , Time Factors
13.
Hum Exp Toxicol ; 27(4): 307-13, 2008 Apr.
Article in English | MEDLINE | ID: mdl-18684801

ABSTRACT

To evaluate whether periconceptional exposure to oral contraceptives (OCs) increased adverse pregnancy outcomes, 136 pregnant women taking OCs within the periconceptional period were identified at the Korean Motherisk Program. Of them, 120 pregnant women accepted to participate in their study and were followed up until completion of the pregnancy. A control group of 240 age- and gravidity-matched pregnant women exposed to non-teratogen drugs for at least 1 month before pregnancy was also included. The median gestational age at delivery was 39.1 (27.0-41.0) weeks in the exposed group and 39.3 (27.4-42.0) weeks in the control group (P = 0.19). In the exposed group, 7.1% of babies were born with low birth weight versus 2.6% in the control group (P = 0.068). The number of preterm deliveries or babies born large for gestational age did not differ between the two groups. In the exposed group, the rate of birth defects was 3.2% (n = 3/99) versus 3.6% (n = 7/193) in the control group (P = 1.0). There were 15 women who took high doses of progesterone (emergency contraception) and no adverse fetal outcomes were observed. In conclusion, periconceptional exposure to OCs does not appear to increase the risk for adverse pregnancy outcomes.


Subject(s)
Contraceptives, Oral/adverse effects , Pregnancy Outcome/epidemiology , Abnormalities, Drug-Induced/epidemiology , Abnormalities, Drug-Induced/etiology , Abortion, Spontaneous/epidemiology , Abortion, Spontaneous/etiology , Abortion, Therapeutic/statistics & numerical data , Adult , Birth Weight/drug effects , Delivery, Obstetric/classification , Delivery, Obstetric/statistics & numerical data , Female , Gestational Age , Humans , Infant, Low Birth Weight , Infant, Newborn , Korea/epidemiology , Maternal Exposure , Pregnancy , Premature Birth/epidemiology , Premature Birth/etiology
14.
Article in English | MEDLINE | ID: mdl-18447144

ABSTRACT

We describe a 20-month-old girl with hypereosinophilia, hyper-immunoglobulin (Ig) E syndrome, and atopic dermatitis. Her peripheral eosinophil count and IgE plasma levels were 2.65 x 10(9)/L and 6702 IU/mL, respectively. Specific IgE levels for a variety of foods and inhalants were high and single-blind food challenges were positive for cow's milk, hen's egg, oat, wheat, and soy. When the patient received an extensively hydrolyzed milk formula, an exclusion diet, and 2 mg/kg of prednisone daily, the atopic dermatitis partially improved. Further improvement was observed with 1 mg/kg of azathioprine daily. Long-term clinical response was satisfactory. We suggest that food hypersensitivity should be ruled out in patients with hypereosinophilia, hyper-IgE syndrome, and atopic dermatitis. Azathioprine may be a good therapeutic alternative for treatment in such cases.


Subject(s)
Dermatitis, Atopic/complications , Food Hypersensitivity/complications , Hypereosinophilic Syndrome/complications , Job Syndrome/complications , Azathioprine/therapeutic use , Bone Marrow Examination , Cell Separation , Combined Modality Therapy , Dermatitis, Atopic/diet therapy , Dermatitis, Atopic/drug therapy , Dermatitis, Atopic/immunology , Diagnosis, Differential , Female , Flow Cytometry , Food Hypersensitivity/diet therapy , Food Hypersensitivity/immunology , Humans , Hypereosinophilic Syndrome/immunology , Immunoglobulins/blood , Infant , Job Syndrome/immunology , Prednisone/therapeutic use
15.
Allergol Immunopathol (Madr) ; 35(6): 239-42, 2007.
Article in English | MEDLINE | ID: mdl-18047814

ABSTRACT

BACKGROUND: The aim of the study was to report the maternal and fetal outcomes of women with respiratory illnesses who were treated with inhaled fluticasone during pregnancy. MATERIAL AND METHODS: We identified 12 cases treated with inhaled fluticasone during pregnancy out of women who received obstetric and teratogen-risk evaluation at the Korean Motherisk Program. A detailed medical and obstetric history was obtained and cases were followed-up until either spontaneous or voluntary pregnancy termination or delivery occurred. RESULTS: None of the participants had any obstetric complication. However, in addition to fluticasone, most of the 12 cases were simultaneously exposed to a variety of medications. There were 3 abortions (one spontaneous and 2 requested by the patients arguing personal reasons). Live born babies without any evidence of major congenital malformations included 8 singleton babies and 2 twins. Of them, 3 babies were born prematurely. CONCLUSIONS: Our results are in agreement with previous large studies where no increased rate of adverse outcomes was reported with the use of inhaled corticosteroids during pregnancy.


Subject(s)
Androstadienes/adverse effects , Anti-Asthmatic Agents/adverse effects , Asthma/drug therapy , Pregnancy Complications/immunology , Pregnancy Outcome , Rhinitis, Allergic, Perennial/drug therapy , Administration, Inhalation , Androstadienes/administration & dosage , Androstadienes/immunology , Anti-Asthmatic Agents/administration & dosage , Anti-Asthmatic Agents/immunology , Asthma/epidemiology , Asthma/immunology , Female , Fluticasone , Humans , Infant , Korea , Pregnancy , Pregnancy Complications/drug therapy , Rhinitis, Allergic, Perennial/epidemiology , Rhinitis, Allergic, Perennial/immunology
16.
Allergol Immunopathol (Madr) ; 35(3): 101-4, 2007.
Article in English | MEDLINE | ID: mdl-17594873

ABSTRACT

BACKGROUND: The aim of this study was to investigate the relationship between food hypersensitivity and atopic dermatitis (AD) in young children. MATERIAL AND METHODS: In a case-control design, 28 patients < 3 years old, with AD and 28 age-matched healthy children were included in the study. A detailed medical history of allergies and timing of weaning was obtained. Children underwent skin tests (prick and patch) to evaluate food hypersensitivity. The status of DA and food allergies in the study participants was investigated 4 years later. RESULTS: There were more children with positive skin tests for food hypersensitivity among cases than controls, OR 4.2 (95%CI 1.3 to 13.4). In contrast, there were no differences in the number of children with positive family history of allergic diseases or weaned at < or = 6 months of age between groups. Four years later, out of the 28 original cases, the state of AD was investigated in 13 (46.4%) infants. Of them, 11 followed an exclusion diet; 6 (46.1%) remained with AD. Of 28 original controls, 15 (51.7%) infants were investigated 4 years later; only one case developed AD. CONCLUSIONS: Young children who had hypersensitivity to cow's milk, hen egg, wheat, fish, soy, or legumes were found to have a higher risk of AD. Positive family history of allergies and early weaning were not found to be relevant risk factors.


Subject(s)
Dermatitis, Atopic/epidemiology , Food Hypersensitivity/epidemiology , Weaning , Case-Control Studies , Child, Preschool , Dermatitis, Atopic/genetics , Female , Follow-Up Studies , Food Hypersensitivity/etiology , Humans , Infant , Male , Mexico/epidemiology , Predictive Value of Tests , Skin Tests
17.
J Obstet Gynaecol ; 27(3): 255-9, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17464805

ABSTRACT

Sildenafil could be an alternative in the treatment of intrauterine growth retardation (IUGR) and premature delivery. In order to systematically review the reproductive-related effects of sildenafil, a search was made on PubMed and the Science Citation Index for studies evaluating the effects of sildenafil on uterine vessels or myometrium either in vitro or in experimental animal models as well as for any clinical trial or case reporting the outcome of pregnant women treated with sildenafil. The information was obtained from: three in vitro studies, five studies performed in experimental animal models, four studies on women with fertility and sterility disorders receiving 100 mg/day of sildenafil intravaginally, and two case reports of pregnant women who received sildenafil for the treatment of pulmonary hypertension. Incubation with sildenafil of different in vitro preparations resulted in vasodilator and uterine relaxant effects. No evidence of teratogenicity was observed in the studies performed in mice, rats and dogs. Sildenafil increased fetal weight in rats. In women, contradictory results on uterine blood flow and endometrial development were reported after the intravaginal administration of sildenafil. No adverse fetal outcomes were reported in the two pregnant women with pulmonary hypertension receiving sildenafil late in their pregnancy. In conclusion, there is still limited information about the efficacy of sildenafil for the treatment of IUGR and premature delivery. However, studies in experimental animal models and two human case reports have reported no deleterious effects on the mother or offspring.


Subject(s)
Fetal Growth Retardation/prevention & control , Obstetric Labor, Premature/prevention & control , Piperazines/therapeutic use , Sulfones/therapeutic use , Tocolytic Agents/therapeutic use , Administration, Intravaginal , Animals , Disease Models, Animal , Female , Humans , Piperazines/administration & dosage , Piperazines/adverse effects , Pregnancy , Purines/administration & dosage , Purines/adverse effects , Purines/therapeutic use , Sildenafil Citrate , Sulfones/administration & dosage , Sulfones/adverse effects , Tocolytic Agents/administration & dosage , Tocolytic Agents/adverse effects
18.
Diabetes Res Clin Pract ; 75(3): 285-91, 2007 Mar.
Article in English | MEDLINE | ID: mdl-16945448

ABSTRACT

This study investigated the effect of an acute bout of exercise (>85% VO2Max) on biochemical, hemodynamic and oxidative stress variables in sedentary and physically active subjects with type 2 diabetes (T2D). Blood measurements were taken before and after a treadmill test on 12 sedentary non-diabetes subjects (ND), 12 sedentary type 2 diabetes (T2S) and 9 physically active T2D subjects (T2DA). T2DS subjects before and after the treadmill test showed a higher plasma glucose (123.2 +/- 19.0 mg/dL versus 108.9 +/- 16.8 mg/dL, p < 0.001), HbA1C (8.7 +/- 2.4% versus 7.3 +/- 1.2%, p < 0.001) and body fat% (21.3 +/- 5.7% versus 34.6 +/- 4.5%, p < 0.001) than T2DA subjects. T2DA had higher VO2Max (37.7 +/- 3.5 versus 29.5 +/- 3.2, p < 0.05), time on treadmill (22.3 +/- 2.1 min versus 16.1 +/- 2.1 min, p < 0.05), hemoglobin (17.9 +/- 0.9 g/dL, p < 0.05) and lower blood pressure levels in comparison to ND and T2DS subjects. Thiobarbituric acid substances (TBARS) in T2DS were higher than in T2DA subjects (0.27 +/- 0.1 nmol/mL versus 0.21 +/- 0.1 nmol/mL, p < 0.05). Glutathione (GSH) levels were similar among the groups. Physically active type 2 diabetes subjects had a more favorable biochemical, hemodynamic and oxidative stress profile than sedentary subjects. The coexistence of a poor cardiopulmonary performance and high oxidative stress environment can determine a profile of high risk for serious cardiovascular events in patients with diabetes.


Subject(s)
Blood Pressure/physiology , Diabetes Mellitus, Type 2/physiopathology , Exercise , Oxidative Stress/physiology , Adult , Blood Glucose/analysis , Diabetes Mellitus, Type 2/blood , Diastole , Exercise Test , Female , Heart Rate , Humans , Male , Middle Aged , Reference Values , Systole , Thiobarbituric Acid Reactive Substances/analysis
19.
J Investig Allergol Clin Immunol ; 16(4): 247-52, 2006.
Article in English | MEDLINE | ID: mdl-16889282

ABSTRACT

BACKGROUND: There is some evidence suggesting a link between paracetamol exposure and atopy in both adults and children. OBJECTIVE: We aimed to investigate whether further epidemiological support for a link between paracetamol intake and allergy could be found in a population of Mexican children. METHODS: In a cross-sectional study design, we applied the ISAAC questionnaire to 3493 children aged 6 to 7 years old. Two analyses were performed: (1) children were classified as cases if they had wheezing, rhinitis, or eczema at any time from their neonatal period up until they reached the age of 6 to 7 years, or as controls if they had never experienced these conditions, and (2) children were classified as cases if they had wheezing, rhinitis, or eczema in the 12 months prior to the study. Paracetamol intake was considered positive if it frequently occurred during the first year of life (first analysis) or in the last 12 months (second analysis). RESULTS: Paracetamol intake in the first year of life was significantly associated with an increased risk of ev having wheezing (adjusted odds ratio [OR], 1.69; 95% confidence interval [CI], 1.23 to 2.34) and rhinitis (adjusted OR, 1.37; 95% CI, 1.20 to 1.59) but not eczema (adjusted OR, 1.45; 95% CI, 0.91 to 2.32). Frequent paracetamol intake in the last year increased the risk of wheezing (OR, 3.3; 95% CI, 1.54 to 7.18), rhinitis (OR, 1.61; 95% CI, 1.33 to 1.95), or eczema (OR, 1.82; 95% CI, 1.24 to 2.66). CONCLUSION: Frequent paracetamol exposure was associated with a significantly increased risk of wheezing and rhinitis and probably eczema in a Mexican population of children.


Subject(s)
Acetaminophen/adverse effects , Dermatitis, Atopic/chemically induced , Respiratory Sounds/etiology , Rhinitis/chemically induced , Acetaminophen/administration & dosage , Analgesics, Non-Narcotic/administration & dosage , Analgesics, Non-Narcotic/adverse effects , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/adverse effects , Case-Control Studies , Child , Child, Preschool , Dermatitis, Atopic/etiology , Dermatitis, Atopic/metabolism , Female , Humans , Hypersensitivity, Immediate/chemically induced , Hypersensitivity, Immediate/etiology , Hypersensitivity, Immediate/metabolism , Infant , Infant, Newborn , Male , Mexico , Oxidative Stress/drug effects , Rhinitis/etiology , Rhinitis/metabolism , Risk Factors , Surveys and Questionnaires
20.
Article in English | MEDLINE | ID: mdl-16784012

ABSTRACT

OBJECTIVE: This study aimed to evaluate the adverse effects of extensively hydrolyzed milk formula on growth in infants and toddlers. METHODS: Prospectively, 45 infants and toddlers with a positive history of cow's milk allergy confirmed by positive skin prick test and high IgE levels for either alpha-lactalbumin, beta-lactoglobulin, or casein and positive single-blind food challenge received extensively hydrolyzed milk formulas for 1 year. Sex-normalized percentiles of heights and weights of infants and toddlers before their enrollment in the study were compared to those at the end of the study. The contribution of breastfeeding, early use of bottle feeding and intake of adapted or special milk formulas, and history of bronchitis and atopic dermatitis on toddlers' growth were also evaluated by multivariate analysis. RESULTS: Similar percentiles of the children's weight and height were observed at the beginning of the study and 1 year later. According to the multivariate analysis, sex, breastfeeding, early bottle feeding, ingestion of adapted or special milk formulas, atopic dermatitis, and bronchitis were not correlated with either the children's weight or height at diagnosis of the allergy or at 1 year of follow-up (P > .10). Weights and heights were not different between toddlers who had atopic dermatitis or bronchitis during the study period and those who did not. CONCLUSIONS: Growth of infants and toddlers with cow's milk allergy was not affected by the intake of extensively hydrolyzed milk for 1 year. Atopic dermatitis and bronchitis did not appear to have any deleterious effect on these children's growth.


Subject(s)
Bronchitis/immunology , Dermatitis/immunology , Infant Formula/chemistry , Milk/immunology , Animals , Body Height , Breast Feeding , Bronchitis/blood , Caseins/metabolism , Dermatitis/blood , Female , Follow-Up Studies , Humans , Immunity, Innate/immunology , Immunoglobulin E/blood , Immunoglobulin E/immunology , Infant , Lactoglobulins/blood , Lactoglobulins/immunology , Male , Milk/adverse effects , Prospective Studies , Single-Blind Method
SELECTION OF CITATIONS
SEARCH DETAIL
...